Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Sermorelin's ability to stimulate the body's own growth hormone production has led to its clinical and off-label uses
1 Why does this matter so much
PMID 12095224
What the evidence supports In the EBCTCG analysis summarized by Oxford Population Health, switching from tamoxifen to an AI in women receiving ovarian suppression reduced breast-cancer recurrence by 21% overall , with the biggest effect during the first five years when treatments differed
Lancet 403 , 10271050 (2024)
US$ 22.07
US$ 27.13
US$ 28.62
US$ 26.38
US$ 22.24
US$ 24.61
US$ 20.08
US$ 25.33
US$ 26.48
